11.02.2016
- US agribusiness giant Monsanto has been handed a civil penalty of $80 million by the Securities and Exchange Commission (SEC) for accounting rules violations related to price...
30.03.2011
- Certificates related to Sanofi-Aventis's $20.1 billion acquisition of U.S. biotech firm Genzyme could begin trading on Nasdaq as soon as April 4, depending on the outcome of its...
